Talking it out: could CBT ease anxiety and depression in IBD patients?
NCT ID NCT05377840
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether cognitive behavioral therapy (CBT) can reduce anxiety and depression in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). Participants receive either psychologist-led or self-administered CBT over 8 weeks. The goal is to see if mental health improves, offering a potential non-drug option for managing these common emotional challenges.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cognitive Behavioral Therapy (CBT)
- What this could lead to
- If it works, this could point toward a drug-free way to improve mental health in people with IBD.
- What could go wrong
- This is a very small, early study with only 13 participants, so results may not apply to everyone. CBT requires time and effort, and not everyone responds.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Can a new pill tame ulcerative colitis Flare-Ups?
- Can switching IBD meds heal the gut when symptoms are quiet?